NCT06179342Completed
Multiple Breath Washout as a Method for Diagnosing Lung Diseases
Comparison of New Methods of Multiple Breath Washout and Diffusion Capacity Determination (Ndd Medizintechnik Zurich, Trueflow™/Truecheck™) With Established Methods of Lung Function Diagnostics in Patients With Idiopathic Pulmonary Fibrosis, Chronic Obstructive Pulmonary Disease, Asthma and Cardiopulmonary Healthy Individuals
Source: ClinicalTrials.gov · Last updated 7 May 2024
Brief summary (registry, in English)
Comparison of the new multiple-breath washout method (ndd Medizintechnik Zürich, Trueflow™/Truecheck™) with established methods of lung function diagnostics in patients with idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, asthma and cardiopulmonary healthy individuals.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 90 (actual)
- First submitted
- 6 Dec 2023
- Start date
- 21 Jun 2021
- Primary completion date
- 1 Mar 2024
- Lead sponsor
- Wissenschaftliches Institut Bethanien e.V
- Diseases
- Idiopathic pulmonary fibrosis, Asthma, COPD
- NCT number
- NCT06179342
What you commit to
- Study type: Observational
- Participants enrolled: 90
- From 21 Jun 2021 to the primary completion date, 1 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Simultaneous presence of at least two of the following diseases (IPF, COPD/emphysema, asthma, pulmonary arterial hypertension)
- any medical, psychological or other condition that restricts the patient's ability to give informed consent for voluntary participation in this trial
Age
- Age \< 18 years
Who the study is looking for
- Age ≥ 18 years
- existing consent
- confirmed diagnosis of one of the following diseases
- idiopathic pulmonary fibrosis (IPF), confirmed according to the guidelines
- chronic obstructive pulmonary disease (COPD) with/without emphysema
- bronchial asthma
- or patients who are admitted with suspected cardiopulmonary dysfunction (e.g. with unclear dyspnoea) and in whom there is no evidence of cardiopulmonary dysfunction during the diagnostic process (comparison group of "healthy" patients).
- Indication for routine performance of the following pulmonary function tests during the current inpatient stay: Whole Body Plethysmography \& Diffusion Capacity of the Lung (single-breath)
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Wissenschaftliches Institut Bethanien e.V. Coordinator of this site? Confirm its status | Solingen | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.